Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling.

Vunnam, Nagamani; Yang, Mu; Lo, Chih Hung; Paulson, Carolyn; Fiers, William D; Huber, Evan; Been, MaryJane; Ferguson, David M; Sachs, Jonathan N

Vunnam, Nagamani; Yang, Mu; Lo, Chih Hung; Paulson, Carolyn; Fiers, William D; Huber, Evan; Been, MaryJane; Ferguson, David M; Sachs, Jonathan N.

Affiliation

Vunnam N; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Yang M; Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Lo CH; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Paulson C; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Fiers WD; Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Huber E; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Been M; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Ferguson DM; Department of Medicinal Chemistry and Center for Drug Design, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Sachs JN; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.

ACS Bio Med Chem Au ; 3(3): 270-282, 2023 Jun 21.

Article in En | MEDLINE | ID: mdl-37363080

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: ACS Bio Med Chem Au Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google